Poster Session at the Breath Biopsy Conference 2024
You can find links to all the posters and poster abstracts on our Community pages.
Poster Session Day One
00:02 Food and Lifestyle Impact on the Exhaled Breath VOCs in Professional Athletes
04:53 Validating Methane and Hydrogen Portable Breath Analyzer AIRE2 Through Calibration Gases
07:59 Development and Validation of a Portable Device for At-Home Hydrogen and Methane Breath Testing
10:37 Tunable Diode Laser High-Resolution Spectroscopic Measurements of the Microbiota Gaseous Biomarkers Kinetics
Poster Session Day Two
00:00 HiSorb TD-GC-MS Innovation: Probing Liver Metabolism with Deuterated EVOCs Unveils Potential Novel Enzymatic Pathways and Biomarkers for Disease Diagnosis
5:55 Volatile Organic Compounds (Vocs) In The Exhaled Breath As Biomarkers For The Early Detection Of Lung Cancer: Application Of Complementary Methodological Approaches
12:04 High sensitivity detection of deuterium-labelled volatile compound probes with Orbitrap-MS: from in-vitro headspace to Breath Biopsy for lung cancer
19:36 Systemic Sclerosis: Can Breathomics help clinicians for ILD management?
24:11 Targeted Breath Biopsy® Profiling Of Induced Biomarkers Unveils A Metabolic Adaptation In Cirrhosis Toward Alcohol Production
30:02 Breath Analysis: Identification Of Potential Volatile Biomarkers For Non-invasive Diagnosis Of Chronic Kidney Disease (Ckd)
36:55 GYNE-VOX: Clinical study for the analysis of volatile organic compound profiles for endometrial cancer screening
41:13 The Breath Analysis For Early Detection Of Malignant Pleural Mesothelioma (Mpm) and Management Of Asbestos Exposure Subjects
45:34 Strategy for Enabling Clinical Confidence in Breath Analysis
50:35 Breath Biopsy® Reveals Promising Voc Biomarkers For Early Detection And Monitoring Of Acute Pulmonary Exacerbations In People With Cystic Fibrosis
55:18 Exploring exhaled breath volatile organic compounds in occupational asthma: A pilot cross-sectional study
59:30 Application of 13C Methacetin Breath Test in Longitudinal Monitoring of Metabolic Dysfunction-Associated Fatty Liver Disease Progression in Children, Adolescents, and Young Adults with History of Childhood Obesity